eFuture Holding Inc $ 6.38 0 (0%)
EFUT News and Headlines - eFuture Holding
Novogen Limited (NVGN)
Shares of Novogen Limited (NVGN) touched an increase in value of more than 50% in extended-hours trading on Tuesday, after the company confirmed that its TRXE-009 is showing the potential to become an important new therapy in the fight against adult and pediatric brain cancer, based on findings from studies conducted at the Feinstein Institute for Medical Research, the research branch of North Shore-LIJ Health System.
The latest study looked at the ability of NVGN's TRXE-009 to kill a library of patient-derived cell cultures from subjects with glioblastoma multiform (GBM). These stemlike cancer cells